Need al­ter­na­tive fund­ing chan­nels? Per­cep­tive Ad­vi­sors now has $675M de­vot­ed to those deals

The glob­al tide of cap­i­tal gush­ing in­to bio­phar­ma isn’t just go­ing through tra­di­tion­al ven­ture funds. As Per­cep­tive Ad­vi­sors is show­ing with their $675 mil­lion fund closed to­day, an in­creas­ing ar­ray of fi­nanc­ing op­tions are open­ing up to small- and mid-sized biotechs.

This is Per­cep­tive’s sec­ond Cred­it Op­por­tu­ni­ties Fund, de­signed to pro­vide “cus­tomized, min­i­mal­ly-di­lu­tive debt fi­nanc­ing so­lu­tions” rang­ing from $10 to $100 mil­lion per in­vest­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER